Janel R Long-Boyle

Janel R Long-Boyle

UNVERIFIED PROFILE

Are you Janel R Long-Boyle?   Register this Author

Register author
Janel R Long-Boyle

Janel R Long-Boyle

Publications by authors named "Janel R Long-Boyle"

Are you Janel R Long-Boyle?   Register this Author

10Publications

255Reads

-Profile Views

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.

N Engl J Med 2019 04;380(16):1525-1534

From the Departments of Bone Marrow Transplantation and Cellular Therapy (E.M., B.T., W.J., S.G.), Hematology (S.Z., Z.M., J.C., J.D., X.T., B.Y.R., M.J.W., B.P.S.), Therapeutics Production and Quality (T.L., M.M.M.), Immunology (H.A., B.Y.), Pharmaceutical Sciences (S.J.C.), Biostatistics (G.K., C.L.), and Infectious Diseases (G.M.), St. Jude Children's Research Hospital, Memphis, TN; the Allergy and Clinical Immunology Division, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru (J.C.A.B.); the Department of Pediatrics, Allergy-Immunology Division, Children's Hospital Los Angeles, Los Angeles (J.A.C.), and the Department of Pediatrics, Division of Pediatric Allergy-Immunology-Bone Marrow Transplantation, University of California, San Francisco (UCSF) Benioff Children's Hospital, San Francisco (J.R.L.-B., J.M.P., M.J.C.) - both in California; the Department of Pediatrics, Pediatric Allergy and Immunology, University of New Mexico, Albuquerque (E.D.); University of Oklahoma Health Sciences Center, Tulsa (J.T.L.); Departamento de Pediatria da Universidade de Taubaté, Conselho Nacional de Medicina, São Paulo (A.C.M.A.); Copperfield Childcare, Claremont, South Africa (H.W.); and the Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (S.S.D.R., H.L.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1815408
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1815408DOI Listing
April 2019

Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.

Int J Pediatr Otorhinolaryngol 2018 Feb 1;105:48-51. Epub 2017 Dec 1.

UCSF-Benioff Children's Hospital, San Francisco, CA, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01655876173057
Publisher Site
http://dx.doi.org/10.1016/j.ijporl.2017.11.034DOI Listing
February 2018

Busulfan after HSCT in children and young adults - Authors' reply.

Lancet Haematol 2017 03;4(3):e103-e104

Division of Pediatrics, Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30018-2DOI Listing
March 2017

Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based Pharmacokinetics.

Drug Metab Lett 2015 ;9(2):80-7

Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
August 2016

Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.

Ther Drug Monit 2015 Apr;37(2):236-45

Departments of *Clinical Pharmacy, and †Bioengineering and Therapeutics, University of California San Francisco; ‡Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY; Departments of §Pharmacy, UCSF Benioff Children's Hospital, and ¶Laboratory Medicine, UCSF Medical Center, University of California San Francisco; ‖Department of Pediatrics, Floating Hospital for Children, Tufts University, Boston, MA; and **Department of Pediatrics, UCSF Benioff Children's Hospital, University of California San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342323PMC
April 2015

Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfan.

Ther Drug Monit 2014 Apr;36(2):169-74

*Department of Laboratory Medicine; †UCSF Medical Center; and ‡Department of Clinical Pharmacy, University of California-San Francisco; and §Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ftd.0000443060.22620.cdDOI Listing
April 2014

Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.

Biol Blood Marrow Transplant 2012 Nov 15;18(11):1656-63. Epub 2012 May 15.

Department of Pediatrics, Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.05.006DOI Listing
November 2012